Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer
The Long Run with Luke Timmerman ›57:18 | Jul 1st, 2025
Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.
57:18 | Jul 1st, 2025
Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.
🎉 Join the #1 community of podcast lovers and never miss a great podcast.
Sign up
Recommendations